Cargando…

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study

OBJECTIVE: The objective of this study was to evaluate how urine drug screening (UDS) frequency is associated with retention in opioid agonist treatment (OAT). METHODS: Data for this retrospective cohort study of 55 921 adults in OAT in Ontario, Canada, were derived from administrative sources betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morin, Kristen A, Dabous, John R, Vojtesek, Frank, Marsh, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Addiction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562722/ https://www.ncbi.nlm.nih.gov/pubmed/36223960 http://dx.doi.org/10.1136/bmjopen-2022-060857

Ejemplares similares

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Evidence of Increased Age and Sex Standardized Death Rates Among Individuals Who Accessed Opioid Agonist Treatment Before the Era of Synthetic Opioids in Ontario, Canada
por: Morin, Kristen A, et al.
Publicado: (2021)

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
por: Bodkin, Claire, et al.
Publicado: (2021)

Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol
por: Guerra-Alejos, B Carolina, et al.
Publicado: (2023)

Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework
por: Tahsin, Farah, et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
por: Rice, Danielle B, et al.
Publicado: (2018)

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
por: Leece, Pamela, et al.
Publicado: (2019)

Evaluating the intended and unintended consequences of opioid-prescribing interventions on primary care in British Columbia, Canada: protocol for a retrospective population-based cohort study
por: Panagiotoglou, Dimitra, et al.
Publicado: (2020)

Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports
por: Crowley, Des, et al.
Publicado: (2020)

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
por: Scott, Gemma, et al.
Publicado: (2023)

Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
por: Piske, Micah, et al.
Publicado: (2020)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia
por: Lam, Tina, et al.
Publicado: (2022)

Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study
por: Qeadan, Fares, et al.
Publicado: (2022)

Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic
por: Kennalley, Amy L, et al.
Publicado: (2023)

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
por: Suarez, Edward, et al.
Publicado: (2023)

Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study
por: Nielsen, Suzanne, et al.
Publicado: (2019)

Comparing rates and characteristics of emergency department presentations related to pharmaceutical opioid poisoning in Australia: a study protocol for a retrospective observational study
por: Lam, Tina, et al.
Publicado: (2020)

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Opioid overdose decedent characteristics during COVID-19
por: Garcia, Gian-Gabriel P., et al.
Publicado: (2022)

Primary care management of Long-Term opioid therapy
por: Coffin, Phillip O., et al.
Publicado: (2022)

Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
por: Jashinski, Julia, et al.
Publicado: (2022)

Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
por: Belcher, Annabelle M, et al.
Publicado: (2019)

Cannabis use among youth in Canada: a scoping review protocol
por: Kourgiantakis, Toula, et al.
Publicado: (2022)

Rewarding recovery: the time is now for contingency management for opioid use disorder
por: Proctor, Steven L.
Publicado: (2022)

Allostatic load in opioid use disorder: a scoping review protocol
por: Fan, Jaimie Qiuyun, et al.
Publicado: (2023)

The opioid crisis: past, present and future policy climate in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2017)

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Quality of life and relapse of Opioid Use Disorder: a scoping review protocol
por: Namatovu, Angella, et al.
Publicado: (2023)

Gambling and the COVID-19 pandemic in the province of Quebec (Canada): protocol for a mixed-methods study
por: Brodeur, Magaly, et al.
Publicado: (2021)

Contingency management for tobacco smoking during opioid addiction treatment: a randomised pilot study
por: Ainscough, Tom Stephen, et al.
Publicado: (2017)

Opioid use disorder in chronic non-cancer pain in Germany: a cross sectional study
por: Just, Johannes Maximilian, et al.
Publicado: (2019)

U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts
por: Bennett, Alex S., et al.
Publicado: (2022)

A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2020)

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018)

What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care
por: Reece, Albert Stuart, et al.
Publicado: (2018)

Risk of behaviour suggestive of opioid abuse: a protocol for a systematic review of validated assessment tools
por: Galindo, Sheila Raposo, et al.
Publicado: (2018)

The changing epidemiology of opioid overdose in Baltimore, Maryland, 2012–2017: insights from emergency medical services
por: Dun, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4lgnkvqmtcusodptl2m5dmhkmi